Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery

被引：17

作者：

Zhan, Peng ^{[1
]}

Li, Wenjun ^{[1
]}

Chen, Hongfei ^{[1
]}

Liu, Xinyong ^{[1
]}

机构：

[1] Shandong Univ, Dept Med Chem, Sch Pharmaceut Sci, Jinan 250012, Shandong, Peoples R China

来源：

CURRENT MEDICINAL CHEMISTRY | 2010年 / 17卷 / 29期

基金：

高等学校博士学科点专项科研基金; 中国国家自然科学基金;

关键词：

HIV; AIDS; drug design; drug targets; protein-protein interactions; inhibitor; HUMAN-IMMUNODEFICIENCY-VIRUS; SMALL-MOLECULE INHIBITORS; REVERSE-TRANSCRIPTASE DIMERIZATION; CYCLOSPORINE-A ANALOG; TSAO DERIVATIVES; NUCLEAR IMPORT; CYCLOPHILIN-A; BINDING-SITE; CONFORMATIONAL-CHANGES; CELLULAR COFACTORS;

D O I：

10.2174/092986710793176357

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

In recent years, the number of useful chemical biology information of protein-protein interactions in the HIV life cycle and related inhibitors, is growing rapidly, which makes protein-protein interactions a new investigative area for antiviral drug intervention. This review will summarize recent work in this field, mainly focusing on the utilization of small molecules targeted against a variety of protein-protein interactions that have great therapeutic feasibility for HIV infection, and lastly outline some other important protein-protein interactions with a potential to advance into novel anti-HIV drug targets in future.

引用

页码：3393 / 3409

页数：17

共 50 条

[11] Drugs targeting protein-protein interactions [J].

Chene, Patrick .

CHEMMEDCHEM, 2006, 1 (04) :400-411

[12] Targeting protein-protein interactions, a wide open field for drug design [J].

Bakail, May ;

Ochsenbein, Francoise .

COMPTES RENDUS CHIMIE, 2016, 19 (1-2) :19-27

[13] Targeting protein-protein interactions in drug discovery: Modulators approved or in clinical trials for cancer treatment [J].

Camps-Fajol, Cristina ;

Cavero, Debora ;

Minguillon, Jordi ;

Surralles, Jordi .

PHARMACOLOGICAL RESEARCH, 2025, 211

[14] Latest animal models for anti-HIV drug discovery [J].

Sliva, Katja .

EXPERT OPINION ON DRUG DISCOVERY, 2015, 10 (02) :111-123

[15] Protein-protein interactions as targets for small molecule drug discovery [J].

Fry, David C. .

BIOPOLYMERS, 2006, 84 (06) :535-552

[16] Targeting Protein-Protein Interactions in Hematologic Malignancies [J].

Cierpicki, Tomasz ;

Grembecka, Jolanta .

ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2025, 20 :275-301

[17] Targeting Protein-Protein Interactions in the HIF System [J].

Wilkins, Sarah E. ;

Abboud, Martine I. ;

Hancock, Rebecca L. ;

Schofield, Christopher J. .

CHEMMEDCHEM, 2016, 11 (08) :773-786

[18] Multivalent Agents: A Novel Concept and Preliminary Practice in Anti-HIV Drug Discovery [J].

Song, Yu'ning ;

Zhan, Peng ;

Li, Xiao ;

Rai, Diwakar ;

De Clercq, Erik ;

Liu, Xinyong .

CURRENT MEDICINAL CHEMISTRY, 2013, 20 (06) :815-832

[19] Small-Molecule Stabilization of Protein-Protein Interactions: An Underestimated Concept in Drug Discovery? [J].

Thiel, Philipp ;

Kaiser, Markus ;

Ottmann, Christian .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2012, 51 (09) :2012-2018

[20] An integrated strategy for the discovery of drug targets by the analysis of protein-protein interactions [J].

Peltier, JM ;

Askovic, S ;

Becklin, RR ;

Chepanoske, CL ;

Ho, YSJ ;

Kery, V ;

Lai, SP ;

Mujtaba, T ;

Pyne, M ;

Robbins, PB ;

von Rechenberg, M ;

Richardson, B ;

Savage, J ;

Sheffield, P ;

Thompson, S ;

Weir, L ;

Widjaja, K ;

Xu, NF ;

Zhen, YJ ;

Boniface, JJ .

INTERNATIONAL JOURNAL OF MASS SPECTROMETRY, 2004, 238 (02) :119-130

← 1 2 3 4 5 →